Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fan Yu

Showing results (891-900 of 969) with videos related to

Pageof 97
Sort By:
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|October 7, 2024
CYLD Maintains Retinal Homeostasis by Deubiquitinating ENKD1 and Promoting the Phagocytosis of Photoreceptor Outer SegmentsSong Yang, Fan Yu, Mulin Yang, et al.
The Journal of Pediatrics|May 2, 2006
Enzyme replacement therapy for mucopolysaccharidosis VI: a phase 3, randomized, double-blind, placebo-controlled, multinational study of recombinant human N-acetylgalactosamine 4-sulfatase (recombinant human arylsulfatase B or rhASB) and follow-on, open-label extension studyPaul Harmatz, Roberto Giugliani, Ida Schwartz, et al.
Mabs|January 31, 2020
Improved translation of stability for conjugated antibodies using an in vitro whole blood assayAimee Fourie-O'Donohue, Phillip Y Chu, Josefa Dela Cruz Chuh, et al.
Oncotarget|October 27, 2017
Loss of Barx1 promotes hepatocellular carcinoma metastasis through up-regulating MGAT5 and MMP9 expression and indicates poor prognosisGuodong Wang, Jian Liu, Yi Cai, et al.
Plos One|July 20, 2023
Key pathological features characterize minimal change disease-like IgA nephropathyTsung-Yueh Wang, Fu-Pang Chang, An-Hang Yang, et al.
Ophthalmology|August 25, 2019
Efficacy, Safety, and Durability of Voretigene Neparvovec-rzyl in RPE65 Mutation-Associated Inherited Retinal Dystrophy: Results of Phase 1 and 3 TrialsAlbert M Maguire, Stephen Russell, Jennifer A Wellman, et al.
Science Translational Medicine|November 20, 2015
Targeting LGR5+ cells with an antibody-drug conjugate for the treatment of colon cancerMelissa R Junttila, Weiguang Mao, Xi Wang, et al.
Nature Cancer|January 30, 2024
Targeted activation of ferroptosis in colorectal cancer via LGR4 targeting overcomes acquired drug resistanceHao Zheng, Jinming Liu, Qi Cheng, et al.
Molecular Genetics and Metabolism|May 15, 2017
Cognitive endpoints for therapy development for neuronopathic mucopolysaccharidoses: Results of a consensus procedureJohanna H van der Lee, Jonathan Morton, Heather R Adams, et al.
Oncotarget|March 31, 2016
ImmunoPET helps predicting the efficacy of antibody-drug conjugates targeting TENB2 and STEAP1Simon-Peter Williams, Annie Ogasawara, Jeff N Tinianow, et al.
Pageof 97

Showing results (891-900 of 969) with videos related to

Sort By:
Pageof 97
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|October 7, 2024
CYLD Maintains Retinal Homeostasis by Deubiquitinating ENKD1 and Promoting the Phagocytosis of Photoreceptor Outer SegmentsSong Yang, Fan Yu, Mulin Yang, et al.
The Journal of Pediatrics|May 2, 2006
Enzyme replacement therapy for mucopolysaccharidosis VI: a phase 3, randomized, double-blind, placebo-controlled, multinational study of recombinant human N-acetylgalactosamine 4-sulfatase (recombinant human arylsulfatase B or rhASB) and follow-on, open-label extension studyPaul Harmatz, Roberto Giugliani, Ida Schwartz, et al.
Mabs|January 31, 2020
Improved translation of stability for conjugated antibodies using an in vitro whole blood assayAimee Fourie-O'Donohue, Phillip Y Chu, Josefa Dela Cruz Chuh, et al.
Oncotarget|October 27, 2017
Loss of Barx1 promotes hepatocellular carcinoma metastasis through up-regulating MGAT5 and MMP9 expression and indicates poor prognosisGuodong Wang, Jian Liu, Yi Cai, et al.
Plos One|July 20, 2023
Key pathological features characterize minimal change disease-like IgA nephropathyTsung-Yueh Wang, Fu-Pang Chang, An-Hang Yang, et al.
Ophthalmology|August 25, 2019
Efficacy, Safety, and Durability of Voretigene Neparvovec-rzyl in RPE65 Mutation-Associated Inherited Retinal Dystrophy: Results of Phase 1 and 3 TrialsAlbert M Maguire, Stephen Russell, Jennifer A Wellman, et al.
Science Translational Medicine|November 20, 2015
Targeting LGR5+ cells with an antibody-drug conjugate for the treatment of colon cancerMelissa R Junttila, Weiguang Mao, Xi Wang, et al.
Nature Cancer|January 30, 2024
Targeted activation of ferroptosis in colorectal cancer via LGR4 targeting overcomes acquired drug resistanceHao Zheng, Jinming Liu, Qi Cheng, et al.
Molecular Genetics and Metabolism|May 15, 2017
Cognitive endpoints for therapy development for neuronopathic mucopolysaccharidoses: Results of a consensus procedureJohanna H van der Lee, Jonathan Morton, Heather R Adams, et al.
Oncotarget|March 31, 2016
ImmunoPET helps predicting the efficacy of antibody-drug conjugates targeting TENB2 and STEAP1Simon-Peter Williams, Annie Ogasawara, Jeff N Tinianow, et al.
Pageof 97